Somatic loss-of-function mutations in the ten-eleven translocation 2 (TET2) gene occur in a significant proportion of patients with myeloid malignancies. Although there are extensive genetic data implicating TET2 mutations in myeloid transformation, the consequences of Tet2 loss in hematopoietic development have not been delineated. We report here an animal model of conditional Tet2 loss in the hematopoietic compartment that leads to increased stem cell self-renewal in vivo as assessed by competitive transplant assays. Tet2 loss leads to a progressive enlargement of the hematopoietic stem cell compartment and eventual myeloproliferation in vivo, including splenomegaly, monocytosis, and extramedullary hematopoiesis. In addition, Tet2(+/-) mice also displayed increased stem cell self-renewal and extramedullary hematopoiesis, suggesting that Tet2 haploinsufficiency contributes to hematopoietic transformation in vivo.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194039 | PMC |
| http://dx.doi.org/10.1016/j.ccr.2011.06.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A mutant ASXL1-BAP1-EHMT complex contributes to heterochromatin dysfunction in clonal hematopoiesis and chronic monomyelocytic leukemia.
Proc Natl Acad Sci U S A
January 2025
Department of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.
is one of the three most frequently mutated genes in age-related clonal hematopoiesis (CH), alongside and (. CH can progress to myeloid malignancies including chronic monomyelocytic leukemia (CMML) and is also strongly associated with inflammatory cardiovascular disease and all-cause mortality in humans. DNMT3A and TET2 regulate DNA methylation and demethylation pathways, respectively, and loss-of-function mutations in these genes reduce DNA methylation in heterochromatin, allowing derepression of silenced elements in heterochromatin.
View Article and Find Full Text PDFSingle cell multiomics reveal divergent effects of DNMT3A and TET2 mutant clonal hematopoiesis in inflammatory response.
Blood Adv
December 2024
Mayo Clinic, Rochester, Minnesota, United States.
DNMT3A and TET2 are epigenetic regulator genes commonly mutated in age-related clonal hematopoiesis (CH). Despite having opposed epigenetic functions, these mutations are associated with increased all-cause mortality and a low risk for progression to hematological neoplasms. While individual impacts on the epigenome have been described using different model systems, the phenotypic complexity in humans remains to be elucidated.
View Article and Find Full Text PDFConcomitant loss of TET2 and TET3 results in T cell expansion and genomic instability in mice.
Commun Biol
December 2024
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Article Synopsis
- * TET2 mutations are common in blood cancers like T cell lymphomas, but mice lacking TET2 alone don't show increased T cell growth, likely due to other TET proteins compensating for its loss.
- * Research involving mice with both TET2 and TET3 deficiencies revealed that losing these proteins leads to harmful changes in T cells, including genetic instability, aneuploidy, and increased levels of the oncogene Myc.
Deficiency of TET2-mediated KMT2D self-transcription confers a targetable vulnerability in hepatocellular carcinoma.
PNAS Nexus
November 2024
Department of Liver Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200120, China.
Article Synopsis
- Hepatocellular carcinoma (HCC) is a major cause of cancer deaths globally, and traditional treatments often worsen patient conditions, highlighting the need for new management strategies.
- Research shows that TET2 and KMT2D work together to regulate important genes involved in HCC, which could be targeted for therapy; KMT2D is particularly important as a tumor suppressor and enhances the anti-cancer effects of vitamin C.
- The study reveals that patients with higher levels of TET2 and KMT2D have better outcomes, suggesting that these proteins play a critical role in HCC progression and could be used as potential targets for treatment.
Letter by Lucijanic and Krecak Regarding Article, "Clonal Hematopoiesis of Indeterminate Potential With Loss of Enhances Risk for Atrial Fibrillation Through Inflammasome Activation".
Circulation
November 2024
Department of Internal Medicine, General Hospital of Sibenik-Knin County, Sibenik, Croatia (I.K.).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!